HD12 for Advanced Stages
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer
- Status
- TERMINATED
- Phase
- NA
Neoadjuvant Treatment of Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE3
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
- Status
- TERMINATED
- Phase
- NA
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer
- Status
- TERMINATED
- Phase
- N/A